Issue 6/2023
The Next Generation of Clinical Trials for Traumatic Brain Injury
Content (40 Articles)
Letter from the Editor-in-Chief: Neurotherapeutics’ Transition to Gold Open Access
M. Maral Mouradian
Pharmacotherapy for Traumatic Brain Injury: The Next Generation of Clinical Trials
Ramon Diaz-Arrastia, Patrick M. Kochanek
Increasing Rigor of Preclinical Research to Maximize Opportunities for Translation
Hannah L. Radabaugh, Adam R. Ferguson, Helen M. Bramlett, W. Dalton Dietrich
An Understated Comorbidity: The Impact of Homelessness on Traumatic Brain Injury
M. Monsour, J.-Y. Lee, C.V. Borlongan
Management Strategies Based on Multi-Modality Neuromonitoring in Severe Traumatic Brain Injury
Christos Lazaridis, Brandon Foreman
Cyclosporine as Therapy for Traumatic Brain Injury
Magnus J. Hansson, Eskil Elmér
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury
Daniel T. Laskowitz, David W. Van Wyck
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
Caroline Lindblad, Elham Rostami, Adel Helmy
N-Acetylcysteine and Probenecid Adjuvant Therapy for Traumatic Brain Injury
Robert S. B. Clark, Philip E. Empey, Patrick M. Kochanek, Michael J. Bell
HMG-CoA Reductase Inhibitors for Traumatic Brain Injury
Kalman Katlowitz, Shankar Gopinath, Jovany Cruz Navarro, Claudia Robertson
Treating Traumatic Brain Injury with Minocycline
Peter J. Bergold, Rachel Furhang, Siobhán Lawless
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
Sonia Villapol, Zachary C. Janatpour, Kwame O. Affram, Aviva J. Symes
Calpain-2 Inhibitors as Therapy for Traumatic Brain Injury
Michel Baudry, Yun Lyna Luo, Xiaoning Bi
Neurosteroid Receptor Modulators for Treating Traumatic Brain Injury
Todd A. Verdoorn, Tom J. Parry, Graziano Pinna, Jonathan Lifshitz
Application of P7C3 Compounds to Investigating and Treating Acute and Chronic Traumatic Brain Injury
Preethy S. Sridharan, Emiko Miller, Andrew A. Pieper
Phosphodiesterase-5 (PDE-5) Inhibitors as Therapy for Cerebrovascular Dysfunction in Chronic Traumatic Brain Injury
Priyanka Kalyani, Sara M. Lippa, J. Kent Werner, Franck Amyot, Carol B. Moore, Kimbra Kenney, Ramon Diaz-Arrastia
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
Amalia Perna, Kathleen S. Montine, Lon R. White, Thomas J. Montine, Brenna A. Cholerton
Functional Brain Networks to Evaluate Treatment Responses in Parkinson’s Disease
János A. Barbero, Prashin Unadkat, Yoon Young Choi, David Eidelberg
Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy
Eleonora S. D’Ambrosio, Jerry R. Mendell
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
Diane Stephenson, Ramona Belfiore-Oshan, Yashmin Karten, Jessi Keavney, D. Kevin Kwok, Terina Martinez, Joe Montminy, Martijn L. T. M. Müller, Klaus Romero, Sudhir Sivakumaran
Optimized Nutrition in Mitochondrial Diseases Correlates with Improved Muscle Fatigue, Strength, and Quality of Life: You Are What You Eat, or Are You?
Russell P. Saneto, Amel Karaa
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
Clara G. Chisari, Assunta Bianco, Vincenzo Brescia Morra, Massimiliano Calabrese, Fioravante Capone, Paola Cavalla, Carlotta Chiavazza, Cristoforo Comi, Maura Danni, Massimo Filippi, Pietro Iaffaldano, Roberta Lanzillo, Salvatore Lo Fermo, Alessandra Lucisano, Alessandra Lugaresi, Giacomo Lus, Gerolama Alessandra Marfia, Fabiana Marinelli, Massimiliano Mirabella, Lucia Moiola, Chiara Perin, Sabrina Realmuto, Simona Toscano, Maria Trojano, Domizia Vecchio, Francesco Patti
Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy
Sean A. Freeman, Bruno Lemarchant, Tifanie Alberto, Julie Boucher, Olivier Outteryck, Myriam Labalette, Stéphanie Rogeau, Sylvain Dubucquoi, Hélène Zéphir
Optimized Nutrition in Mitochondrial Disease Correlates to Improved Muscle Fatigue, Strength, and Quality of Life
Donna DiVito, Amanda Wellik, Jessica Burfield, James Peterson, Jean Flickinger, Alyssa Tindall, Kimberly Albanowski, Shailee Vishnubhatt, Laura MacMullen, Isaac Martin, Colleen Muraresku, Elizabeth McCormick, Ibrahim George-Sankoh, Shana McCormack, Amy Goldstein, Rebecca Ganetzky, Marc Yudkoff, Rui Xiao, Marni J. Falk, Maria R. Mascarenhas, Zarazuela Zolkipli-Cunningham
Arterial Glyceryl Trinitrate in Acute Ischemic Stroke After Thrombectomy for Neuroprotection (AGAIN): A Pilot Randomized Controlled Trial
Zhe Cheng, Jie Gao, Yuchuan Ding, Qi Pang, Gary B. Rajah, Xiaokun Geng
Magnetic Resonance-Guided Focused Ultrasound Thalamotomy Rebalances Atypical Functional Hierarchy in Patients with Essential Tremor
Jiaji Lin, Xiaopeng Kang, Haoxuan Lu, Dekang Zhang, Xianbing Bian, Jiayou Zhou, Jianxing Hu, Dong Zhang, Jorge Sepulcre, Longsheng Pan, Xin Lou
Wavelet-Based Bracketing, Time–Frequency Beta Burst Detection: New Insights in Parkinson’s Disease
Tanmoy Sil, Ibrahem Hanafi, Hazem Eldebakey, Chiara Palmisano, Jens Volkmann, Muthuraman Muthuraman, Martin M. Reich, Robert Peach
Therapeutic Effects of Combination of Nebivolol and Donepezil: Targeting Multifactorial Mechanisms in ALS
Soo Yeon Lee, Hye-Yeon Cho, Jung-Pyo Oh, Jiae Park, Sang-Hun Bae, Haesun Park, Eun Jung Kim, Ji-Hyun Lee
Frequency-Dependent Reduction of Cybersickness in Virtual Reality by Transcranial Oscillatory Stimulation of the Vestibular Cortex
Alberto Benelli, Francesco Neri, Alessandra Cinti, Patrizio Pasqualetti, Sara M. Romanella, Alessandro Giannotta, David De Monte, Marco Mandalà, Carmelo Smeralda, Domenico Prattichizzo, Emiliano Santarnecchi, Simone Rossi
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model
Katherine J. Donohue, Bethany Fitzsimmons, Ronald C. Bruntz, Kia H. Markussen, Lyndsay E. A. Young, Harrison A. Clarke, Peyton T. Coburn, Laiken E. Griffith, William Sanders, Jack Klier, Sara N. Burke, Andrew P. Maurer, Berge A. Minassian, Ramon C. Sun, Holly B. Kordasiewisz, Matthew S. Gentry
Persistent NRG1 Type III Overexpression in Spinal Motor Neurons Has No Therapeutic Effect on ALS-Related Pathology in SOD1G93A Mice
Sara Hernández, Sara Salvany, Anna Casanovas, Lídia Piedrafita, M. Clara Soto-Bernardini, Olga Tarabal, Alba Blasco, Sílvia Gras, Alaó Gatius, Markus H. Schwab, Jordi Calderó, Josep E. Esquerda
Intravenous Administration of an AAV9 Vector Ubiquitously Expressing C1orf194 Gene Improved CMT-Like Neuropathy in C1orf194-/- Mice
Zongrui Shen, Meiyi Li, Fei He, Cheng Huang, Yingchun Zheng, Zhikui Wang, Shunfei Ma, Li Chen, Zhengshan Liu, Hui Zheng, Fu Xiong
Dihydromyricetin Alleviates Ischemic Brain Injury by Antagonizing Pyroptosis in Rats
Huiru Ding, Quancheng Cheng, Xuan Fang, Ziyuan Wang, Jinyu Fang, Huaicun Liu, Junwei Zhang, Chunhua Chen, Weiguang Zhang
Recombinant Erythropoietin Induces Oligodendrocyte Progenitor Cell Proliferation After Traumatic Brain Injury and Delayed Hypoxemia
Kirill Shumilov, Sophia Xiao, Allen Ni, Marta Celorrio, Stuart H. Friess
D1R-5-HT2AR Uncoupling Reduces Depressive Behaviours via HDAC Signalling
Weifen Li, Tahir Ali, Shengnan Mou, Qichao Gong, Ningning Li, Liangliang Hao, Zhi-Jian Yu, Shupeng Li
Correction: Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
Diane Stephenson, Ramona Belfiore-Oshan, Yashmin Karten, Jessi Keavney, D. Kevin Kwok, Terina Martinez, Joe Montminy, Martijn L. T. M. Müller, Klaus Romero, Sudhir Sivakumaran
Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology
Shalini S. Rao, Larissa Lago, Irene Volitakis, Jay J. Shukla, Gawain McColl, David I. Finkelstein, Paul A. Adlard
Retraction Note: Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
Nora Hegazy, Samar Rezq, Ahmed Fahmy